CYTOSORBENTS CORPORATION Public Float
CYTOSORBENTS CORPORATION (CTSO) had Public Float of $60.60 million as of 2025-06-30, per its 10-K/A filed 2026-04-15.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-15
- 2025-06-30: Entity Public Float $60.60M.
- 2024-06-28: Entity Public Float $37.10M.
- 2023-06-30: Entity Public Float $143.85M.
- 2022-12-31: Entity Public Float $61.46M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $60.60M 10-K/A · filed 2026-04-15 |
| 2024-06-28 | $37.10M 10-K · filed 2025-03-31 |
| 2023-06-30 | $143.85M 10-K · filed 2024-03-15 |
| 2022-12-31 | $61.46M 10-K · filed 2023-03-09 |
| 2021-06-30 | $263.36M 10-K · filed 2022-03-10 |
| 2020-06-30 | $306.29M 10-K · filed 2021-03-09 |
| 2019-06-30 | $178.69M 10-K · filed 2020-03-05 |
| 2018-06-30 | $320.08M 10-K · filed 2019-03-07 |
| 2017-06-30 | $107.83M 10-K · filed 2018-03-08 |
| 2016-06-30 | $102.00M 10-K · filed 2017-03-03 |
| 2015-06-30 | $104.00M 10-K · filed 2016-03-09 |
| 2014-06-30 | $72.14M 10-K · filed 2015-03-31 |
| 2013-06-30 | $27.66M 10-K · filed 2014-03-31 |
| 2012-06-30 | $20.62M 10-K · filed 2013-04-03 |
| 2011-06-30 | $32.79M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |